Pardes Biosciences has assembled a Management Team, Board of Directors, and panel of strategic Scientific and Commercial Advisors with significant experience in discovering, developing, and commercializing a broad range of therapeutics.
The Pardes Biosciences Team is committed to innovating every aspect of our business as we attempt to solve some of the world’s most pressing public health challenges.

Management Team

Uri Lopatin
Uri Lopatin, MD
Chief Executive Officer & President
Lee Arnold
Lee Arnold, PhD
Chief Scientific Officer
Brian Kearney
Brian Kearney, PharmD
Chief Development Officer
Heidi Henson
Heidi Henson
Chief Financial Officer
Elizabeth Lacy
Elizabeth Lacy, JD
General Counsel and Corporate Secretary
Sean Brusky
Sean Brusky
Chief Commercial Officer

Board of Directors

Mark Auerbach
Mark Auerbach, CPA
Board Chair
Jim Tananbaum
Jim Tananbaum, MD
Board Member
Uri Lopatin
Uri Lopatin, MD
Board Member
Jay Lobell
Jay Lobell
Board Member
Mike Varney
Mike Varney, PhD
Board Member
Clifford Samuel
Laura J. Hamill
Board Member
Clifford Samuel
Deborah M. Autor
Board Member

Strategic Advisors

Carol Brosgart
Carol Brosgart, MD
Scientific Advisory Board
Robert Zamboni
Robert Zamboni, PhD
Scientific Advisory Board
Mike Varney
Mike Varney, PhD
Scientific Advisory Board
Clifford Samuel
Kenneth Bernard, MD
Scientific Advisory Board
Clifford Samuel
Clifford Samuel
Commercial Advisory Board
Brad Jenkins
Brad Jenkins
Commercial Advisory Board
Brad Jenkins
Philippe Tinmouth
Commercial Advisory Board